Failure in the implantation of drug eluting stents. Frequency and related factors;Fracaso en la implantación de stent liberadores de fármacos. Frecuencia y factores relacionados

Medicina Intensiva

Volumn 31, Issue 8, 2007, Pages 423-427

  Ferrer Gracia, M C ^a,b   Moreno, R ^a   Perez Vizcayno M J ^a   Hernandez Antolin R ^a   Alfonso Manterola, F ^a   Sabate Tenas M ^a   Escaned Barbosa, J ^a   Banuelo De Lucas C ^a   Macaya Miguel, C ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Coronary angiography; Drug eluting stent; Failure stent deployment

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CALCIUM; CLOPIDOGREL; HEPARIN; PACLITAXEL; RAPAMYCIN; TIROFIBAN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; MALE; PERIPHERAL VASCULAR DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 36248998141     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/S0210-5691(07)74852-0     Document Type: Article

References (18)

1. Hill RA, Dundar Y, Bakhai A, Dickson R, Walley T. Drugeluting stents: an early systematic review to inform policy. Eur Heart J. 2004;25:902-19.
2. Baroletti A, Maden A. Drug-eluting stents: a pharmacy management perspective. Formulary. 2004;39:446-57.
3. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99:44-52.
4. Moreno R. Drug-eluting stents and other anti-restenosis devices. Rev Esp Cardiol. 2005;58:842-62.
5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
7. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43:1110-5.
8. Schofer J, Schluter M, Gershlick AH, Wijns W, García E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093-9.
9. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-94.
10. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42.
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31.
12. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation. 2004;109:1366-70.
13. Fonseca N, Moreno R, Pérez M, Alfonso F, Hernández R, Escaned J, et al. Predictors of failure in direct stenting in the real world. Rev Port Cardiol. 2004;23:951-60.
14. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653-62.
15. Kastrati A, Dibra A, Eberle S, Mehilli J, Suárez de Lezo J, Goy JJ, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005;294:819-25.
16. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA. 2006;295:895-904.
17. Oliva G, Espallargues M, Pons JM. Antiproliferative drugeluting stents: systematic review of the benefits and estimate of economic impact. Rev Esp Cardiol. 2004;57:617-28.
18. Nikolsky E, Gruberg L, Pechersky S, Kapeliovich M, Grenadier E, Amikam S, et al. Stent deployment failure: reasons, implications, and short- and long-term outcomes. Catheter Cardiovasc Interv. 2003;59:324-8.